Showing results (451-460 of 479) with videos related to
Sort By:
Pageof 48
JCO Oncology Practice|May 11, 2022
Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series AnalysisNahomy Ledesma Vicioso, Diana Lin, Daniel R Gomez, et al.International Journal of Radiation Oncology, Biology, Physics|October 3, 2025
Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study)Linda Chen, Marc Cohen, Vaios Hatzglou, et al.Oral Oncology|February 17, 2026
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinomaJennifer R Cracchiolo, Fergal Kavanagh, Michael T Starc, et al.International Journal of Cancer|October 15, 2019
Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancerThomas H Beckham, Christian Barney, Erin Healy, et al.The American Journal of Surgical Pathology|July 15, 2021
IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases With Favorable OutcomeStefanie Glöss, Philipp Jurmeister, Anne Thieme, et al.JAMA Oncology|July 22, 2016
The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing PlatformLuc G T Morris, Raghu Chandramohan, Lyndsay West, et al.Journal of Medicinal Chemistry|February 8, 2022
Design and Development of Glucocorticoid Receptor Modulators as Immunology Antibody-Drug Conjugate PayloadsAdrian D Hobson, Michael J McPherson, Wendy Waegell, et al.Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.Cancer|July 9, 2020
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancerJung Julie Kang, Richard J Wong, Eric J Sherman, et al.Journal of Medicinal Chemistry|September 1, 2023
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)Adrian D Hobson, Jianwen Xu, Dennie S Welch, et al.Pageof 48